Use of a bioengineered antioxidant in mouse models of metabolic syndrome

References

• O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16:1–12.
   PubMed Web of Science ®Google Scholar
• Aguilar M, Bhuket T, Torres S, et al. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA. 2015;313:1973–1974.
   PubMed Web of Science ®Google Scholar
• Rani V, Deep G, Singh RK, et al. Oxidative stress and metabolic disorders: pathogenesis and therapeutic strategies. Life Sci. 2016;148:183–193.
   PubMed Web of Science ®Google Scholar
• Hasnain SZ, Prins JB, McGuckin MA. Oxidative and endoplasmic reticulum stress in β-cell dysfunction in diabetes. J Mol Endocrinol. 2016;56:R33–R54.
   PubMed Web of Science ®Google Scholar
• Newsholme P, Cruzat VF, Keane KN, et al. Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochem J. 2016;473:4527–4550.
   PubMed Web of Science ®Google Scholar
• Sekhar RV, Patel SG, Guthikonda AP, et al. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am. J. Clin. Nutr. 2011;94:847–853.
   PubMed Web of Science ®Google Scholar
• Kamata H, Honda S-I, Maeda S, et al. Reactive oxygen species promote TNF alpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell. 2005;120:649–661.
   PubMed Web of Science ®Google Scholar
• Seki E, Brenner DA, Karin M. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology. 2012;143:307–320.
   PubMed Web of Science ®Google Scholar
• Nakatani Y, Kaneto H, Kawamori D, et al. Modulation of the JNK pathway in liver affects insulin resistance status. J Biol Chem. 2004;279:45803–45809.
   PubMed Web of Science ®Google Scholar
• Vinayagamoorthi R, Bobby Z, Sridhar MG. Antioxidants preserve redox balance and inhibit c-Jun-N-terminal kinase pathway while improving insulin signaling in fat-fed rats: evidence for the role of oxidative stress on IRS-1 serine phosphorylation and insulin resistance. J Endocrinol. 2008;197:287–296.
   PubMed Web of Science ®Google Scholar
• Higuchi M, Dusting GJ, Peshavariya H, et al. Differentiation of human adipose-derived stem cells into fat involves reactive oxygen species and Forkhead box O1 mediated upregulation of antioxidant enzymes. Stem Cells Dev. 2013;22:878–888.
   PubMed Web of Science ®Google Scholar
• Lee H, Lee YJ, Choi H, et al. Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion. J Biol Chem. 2009;284:10601–10609.
   PubMed Web of Science ®Google Scholar
• Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2017;114:1752–1761.
   Google Scholar
• Lavine JE, Schwimmer JB, Van Natta ML, et al. Effect of vitamin Eor metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA. 2011;305(16):1659–1668.
   Web of Science ®Google Scholar
• Kim GH, Chung JW, Lee JH, et al. Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study. Clin. Mol. Hepatol. Clin. Mol. Hepatol. 2015;21:379–386.
   PubMed Web of Science ®Google Scholar
• Sarkhy AA, Al-Hussaini AA, Nobili V. Does vitamin e improve the outcomes of pediatric nonalcoholic fatty liver disease? A systematic review and meta-analysis. Saudi J Gastroenterol Off J Saudi Gastroenterol Assoc. 2014;20:143–153.
   PubMed Web of Science ®Google Scholar
• Bjelakovic G, Nikolova D, Gluud LL, et al. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2012 Mar 14;(3):CD007176.
   Google Scholar
• Etsuo Niki JT. Regeneration of vitamin E from .ALPHA.-chromanoxyl radical by glutathione and vitamin C. Chem Lett - CHEM LETT. 1982;789–792. DOI:10.1246/cl.1982.789
   Web of Science ®Google Scholar
• Murer SB, Aeberli I, Braegger CP, et al. Antioxidant supplements reduced oxidative stress and stabilized liver function tests but did not reduce inflammation in a randomized controlled trial in obese children and adolescents. J. Nutr. 2014;144:193–201.
   PubMed Web of Science ®Google Scholar
• Price BK, Lomeda JR, Tour JM. Aggressively oxidized ultra-short single-walled carbon nanotubes having oxidized sidewalls. Chem Mater. 2009;21:3917–3923.
   Web of Science ®Google Scholar
• Lucente-Schultz RM, Moore VC, Leonard AD, et al. Antioxidant single-walled carbon nanotubes. J Am Chem Soc. 2009;131:3934–3941.
   PubMed Web of Science ®Google Scholar
• Marcano DC, Bitner BR, Berlin JM, et al. Design of poly(ethylene glycol)-functionalized hydrophilic carbon clusters for targeted therapy of cerebrovascular dysfunction in mild traumatic brain injury. J Neurotrauma. 2013;30:789–796.
   PubMed Web of Science ®Google Scholar
• Samuel ELG, Duong MT, Bitner BR, et al. Hydrophilic carbon clusters as therapeutic, high-capacity antioxidants. Trends Biotechnol. 2014;32:501–505.
   PubMed Web of Science ®Google Scholar
• Samuel ELG, Marcano DC, Berka V, et al. Highly efficient conversion of superoxide to oxygen using hydrophilic carbon clusters. Proc. Natl. Acad. Sci. 2015;112:2343–2348.
   PubMed Web of Science ®Google Scholar
• Berlin JM, Leonard AD, Pham TT, et al. Effective drug delivery, in vitro and in vivo, by carbon-based nanovectors noncovalently loaded with unmodified Paclitaxel. ACS Nano. 2010;4:4621–4636.
   PubMed Web of Science ®Google Scholar
• Bitner BR, Marcano DC, Berlin JM, et al. Antioxidant carbon particles improve cerebrovascular dysfunction following traumatic brain injury. ACS Nano. 2012;6:8007–8014.
   PubMed Web of Science ®Google Scholar
• Inoue T, Griffin, DM, Huq, R, et al. Characterization of a novel MR-detectable nanoantioxidant that mitigates the recall immune response. NMR Biomed. 2016;29:1436–1444.
   PubMed Web of Science ®Google Scholar
• Huq R, Samuel ELG, Sikkema WKA, et al. Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation. Sci Rep. 2016;6:33808.
   PubMed Web of Science ®Google Scholar
• Anstee QM, Goldin RD. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol. 2006;87:1–16.
   PubMed Web of Science ®Google Scholar
• King A, Bowe J. Animal models for diabetes: understanding the pathogenesis and finding new treatments. Biochem Pharmacol. 2016;99:1–10.
   PubMed Web of Science ®Google Scholar
• Nowotny K, Jung T, Höhn A, et al. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules. 2015;5:194–222.
   PubMed Web of Science ®Google Scholar
• Yamagishi S, Matsui T. Advanced glycation end products (AGEs), oxidative stress and diabetic retinopathy. Curr Pharm Biotechnol. 2011;12:362–368.
   PubMed Web of Science ®Google Scholar
• Brings S, Fleming T, Freichel M, et al. Dicarbonyls and advanced glycation end-products in the development of diabetic complications and targets for intervention. Int. J. Mol. Sci. 2017;18:984.
   Web of Science ®Google Scholar
• Byun K, Yoo Y, Son M, et al. Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases. Pharmacol. Ther. 2017;177:44–55.
   PubMed Web of Science ®Google Scholar
• García-Ruiz C, Colell A, Morales A, et al. Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes. Mol Pharmacol. 1995;48:825–834.
   PubMed Web of Science ®Google Scholar
• Pérez-Carreras M, Del Hoyo P, Martín MA, et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology. 2003;38:999–1007.
   PubMed Web of Science ®Google Scholar
• García-Ruiz I, Rodríguez-Juan C, Díaz-Sanjuan T, et al. Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice. Hepatology. 2006;44:581–591.
   PubMed Web of Science ®Google Scholar
• Marseglia L, Manti S, D’Angelo G, et al. Oxidative stress in obesity: a critical component in human diseases. Int. J. Mol. Sci. 2014;16:378–400.
   PubMed Web of Science ®Google Scholar
• James OFW, Day CP. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J. Hepatol. 1998;29:495–501.
   PubMed Web of Science ®Google Scholar
• Marchesini G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37:917–923.
   PubMed Web of Science ®Google Scholar
• Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med. 2012;52:59–69.
   PubMed Web of Science ®Google Scholar
• Koek GH, Liedorp PR, Bast A. The role of oxidative stress in non-alcoholic steatohepatitis. Clin Chim Acta Int J Clin Chem. 2011;412:1297–1305.
   PubMed Web of Science ®Google Scholar
• Yesilova Z, Yaman H, Oktenli C, et al. systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease. Am. J. Gastroenterol. 2005;100:850–855.
   PubMed Web of Science ®Google Scholar
• Narasimhan S, Gokulakrishnan K, Sampathkumar R, et al. Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes. Clin. Biochem. 2010;43:815–821.
   PubMed Web of Science ®Google Scholar
• García-Monzón C, Martín-Pérez E, Iacono OL. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol. 2000;33:716–724.
   PubMed Web of Science ®Google Scholar
• Keane KN, Cruzat VF, Carlessi R, et al. molecular events linking oxidative stress and inflammation to insulin resistance and β-cell dysfunction. Oxid Med Cell Longev. 2015;2015:e181643.
   PubMed Web of Science ®Google Scholar
• Li H, Yu X. Emerging role of JNK in insulin resistance. Curr Diabetes Rev. 2013;9:422–428.
   PubMedGoogle Scholar
• Weston CR, Davis RJ. The JNK signal transduction pathway. Curr Opin Cell Biol. 2007;19:142–149.
   PubMed Web of Science ®Google Scholar
• Al-Busafi SA, Bhat M, Wong P, et al. Antioxidant therapy in nonalcoholic steatohepatitis. Hepat Res Treat. 2012;2012:e947575.
   PubMedGoogle Scholar
• Hwang HJ, Jung TW, Kim BH, et al. A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression. Biochem Pharmacol. 2015;98(1):157–166.
   PubMed Web of Science ®Google Scholar
• Wang B, Chandrasekera P, Pippin JJ. Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes. Curr Diabetes Rev. 2014;10:131–145.
   PubMedGoogle Scholar
• Iikuni N, Lam QLK, Lu L, et al. Leptin and inflammation. Curr Immunol Rev. 2008;4:70–79.
   PubMedGoogle Scholar
• Harris RBS. Direct and indirect effects of leptin on adipocyte metabolism. Biochim. Biophys. Acta BBA - Mol. Basis Dis. 2014;1842:414–423.
   PubMed Web of Science ®Google Scholar
• Lindström P. The physiology of obese-hyperglycemic mice [ob/ob mice]. Sci World J. 2007;7:666–685.
   Web of Science ®Google Scholar
• Lindström P. β-Cell Function in Obese-Hyperglycemic Mice [ob/ob Mice]. Adv Exp Med Biol. 2010:463–477.
   Google Scholar
• Gerriets VA, MacIver NJ. Role of T cells in malnutrition and obesity. Front Immunol. 2014;5.
   PubMed Web of Science ®Google Scholar
• Cipolletta D. Adipose tissue-resident regulatory T cells: phenotypic specialization, functions and therapeutic potential. Immunology. 2014 Aug;142(4):517–525.
   Web of Science ®Google Scholar
• Wensveen FM, Valentić S, Šestan M, et al. The “Big Bang” in obese fat: events initiating obesity-induced adipose tissue inflammation. Eur J Immunol. 2015;45:2446–2456.
   PubMed Web of Science ®Google Scholar
• Asghar A, Sheikh N. Role of immune cells in obesity induced low grade inflammation and insulin resistance. Cell Immunol. 2017;315:18–26.
   PubMed Web of Science ®Google Scholar
• Berlin JM, Pham TT, Sano D, et al. Noncovalent functionalization of carbon nanovectors with an antibody enables targeted drug delivery. ACS Nano. 2011;5:6643–6650.
   PubMed Web of Science ®Google Scholar
• Kim GH, Chung JW, Lee JH, et al. Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study. Clin Mol Hepatol Clin Mol Hepatol. 2015;21:379–386.
   PubMed Web of Science ®Google Scholar
• Sarkhy AA, Al-Hussaini AA, Nobili V. does vitamin e improve the outcomes of pediatric nonalcoholic fatty liver disease? a systematic review and meta-analysis. Saudi J Gastroenterol Off J Saudi Gastroenterol Assoc. 2014;20:143–153.
   PubMed Web of Science ®Google Scholar
• Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. J Am Med Assoc. 2005;293(11):1338–1347.
   PubMed Web of Science ®Google Scholar
• Upston JM, Terentis AC, Morris K, et al. Oxidized lipid accumulates in the presence of α-tocopherol in atherosclerosis. Biochem J. 2002;363(3):753–760.
   PubMedGoogle Scholar
• Lee SH, Oe T, Blair IA. Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science. 2001;292(5524):2083–2086.
   PubMed Web of Science ®Google Scholar